Skip to main content
Loading...
Biological Pathway
Cite
Metformin
Complex I inhibited at mitochondrial inner membrane
hepatic gluconeogenesis reduced
circulating insulin levels reduced
IGF-1 bioavailability reduced (elevated IGFBP-1)
IGF-1R(Tyr1135/Tyr1136) autophosphorylation reduced
IRS-1(Tyr612) phosphorylation reduced
PI3K(p110α) recruitment to IRS-1 reduced
AKT(Thr308/Ser473) phosphorylation reduced
MDM2(Ser166) phosphorylation by AKT reduced
p53 stabilization elevated
Cancer
Score: 0.90
11 hops
Pathway Hops
INHIBITS
Confidence: 95%
INHIBITS
Confidence: 95%
INHIBITS
Confidence: 95%
CAUSES
Confidence: 95%
PHOSPHORYLATES
Confidence: 95%
PHOSPHORYLATES
Confidence: 95%
PHOSPHORYLATES
Confidence: 95%
PHOSPHORYLATES
Confidence: 95%
PHOSPHORYLATES
Confidence: 95%
PHOSPHORYLATES
Confidence: 95%
INHIBITS
Confidence: 95%
Discovered by InTree.AI — analyzing 250M+ scientific papers
Metformin → Cancer — Biological Pathway | InTree.AI | InTree